Driven to develop novel inhalation technologies
Ventus Medical is a development company specialising in the innovation of novel inhalation and NRT smoking cessation technologies. We bring together the expertise needed to create, develop and protect products that have the potential to benefit public health.
Our goal is to address the greatest public health challenges by realising safe and effective tools that can be deployed by policymakers to reduce morbidity and mortality and improve the quality of life of the general population.
In order to deliver the best outcomes and create NRT products that safely help to stop smoking cravings, our team has developed an agile way of working. With our dedicated specialists fostering an environment of quality and creativity, we’re uniquely positioned to deliver truly ground-breaking technologies.
Location
Pioneering inhalation NRT and drug delivery from the UK
From history to the future
Somewhat ironically, our home is located in the ‘Matchworks’ a former match factory in Liverpool, UK. Formally known as the Mersey Match Factory, the site opened in 1921 and stood as the final working match factory in England – a long history related to nicotine products stemming back nearly 100 years and continuing with our NRT smoking alternatives.
The factory was taken over by Swedish Match in the 1980s before being transformed into its current form and our home. A Grade II listed building located on an extensive green sanctuary repurposed as the home of next-generation nicotine and NRT products, this building is symbolic of our mission in changing the smoking paradigm and shaping a smoke-free future.
Leadership team
The team behind our success
Ventus Medical is led by a team of experienced experts in their fields. The bringing together of pharmaceutical experience, regulatory expertise, and unique industry insights has driven the rapid formation of the company and our success in developing quality NRT smoking cessation devices.
QP and Quality Expert on the e-VOKE project, Mark has had a long career in the pharmaceutical industry. A chemist by education, Mark further developed his career in the pharmaceutical industry by qualifying as a European ‘Qualified Person’. Mark was responsible for the establishment of a world-class ENDS manufacturing site comprising 15 Grade D-GMP clean rooms and achieving GMP certification for the site at Nerudia.
In his spare time, Mark enjoys family life and spends his time on various sailing adventures off the Welsh coast.
Having led the development of the world’s first medically approved electronic cigarette, e-VOKE, David was responsible for the establishment of a world-class regulatory consultancy in Nerudia.
A biochemist by education, David has continued his personal development by completing an MBA in Alliance Manchester Business School and is now competing a BLL Law.
In his free time, David can be found flying in the clouds in UK airspace.